Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

4.54
-0.1000-2.16%
Post-market: 4.540.00000.00%19:55 EST
Volume:831.49K
Turnover:3.79M
Market Cap:873.15M
PE:-20.21
High:4.70
Open:4.65
Low:4.51
Close:4.64
52wk High:5.10
52wk Low:2.71
Shares:192.32M
Float Shares:126.05M
Volume Ratio:0.50
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2246
EPS(LYR):-0.3767
ROE:-45.88%
ROA:-16.46%
PB:11.28
PE(LYR):-12.05

Loading ...

Trevi Therapeutics Names David Hastings CFO

MT Newswires Live
·
Dec 04

Arbutus Biopharma Q3 Revenue USD 500 Thousand

Reuters
·
Nov 20

Arbutus Biopharma Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 15

Arbutus Biopharma Q3 revenue and net loss miss analyst estimates

Reuters
·
Nov 13

Earnings Flash (ABUS) Arbutus Biopharma Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.03 Loss

MT Newswires Live
·
Nov 13

Arbutus Biopharma Unveils Progress Toward Functional Cure for Chronic Hepatitis B

Reuters
·
Nov 13

Arbutus Biopharma reports $93.7 million in cash and marketable securities in Q3 2025

Reuters
·
Nov 13

BRIEF-Arbutus Biopharma Q3 Revenue USD 500 Thousand

Reuters
·
Nov 13

Top News Today: Stocks Mostly Higher on Government Reopening Hopes

Dow Jones
·
Nov 12

Arbutus Biopharma Corp expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
Oct 31

Arbutus Biopharma to present imdusiran, AB-101 data at The Liver Meeting 2025

TIPRANKS
·
Oct 07

Arbutus Biopharma Corp. Announces Filing of New Patent Application for Innovative Lipid Nanoparticle Technology

Reuters
·
Sep 10

Arbutus Biopharma Q2 EPS $0.01 Beats $(0.05) Estimate, Sales $10.74M Beat $1.59M Estimate

Benzinga
·
Aug 06

BRIEF-Arbutus Biopharma Q2 Revenue USD 10.7 Million Vs. IBES Estimate USD 1.59 Million

Reuters
·
Aug 06

Arbutus Biopharma Reports Q2 2025 Revenue Surge to $10.7M, Achieves Net Income of $2.5M, EPS at $0.01

Reuters
·
Aug 06

Arbutus Biopharma Q2 Cash & Investments USD 98.1 Million

THOMSON REUTERS
·
Aug 06

Arbutus Biopharma Corp expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Jul 28

Arbutus Biopharma Reacquires Rights to Imdusiran in China

MT Newswires Live
·
Jun 25

BRIEF-Arbutus Reacquires Greater China Rights to Imdusiran

Reuters
·
Jun 25

Arbutus Biopharma Corp. Announces New Scientific Advisory Board with Focus on Late-Stage Clinical Trials

Reuters
·
Jun 25